Professor Mueller has extensive experience in conducting international, multi-center trials, and has worked through well-established consortia, including the Children’s Oncology Group and the Pacific Pediatric Neuro-Oncology Consortium (PNOC), which she currently leads. PNOC’s focus is on the development and swift implementation of early-phase clinical trials, along with improving access to innovative therapies through international partnerships across Europe, Israel, Egypt, Canada, and Australia for children and young adults with brain tumors. Additionally, leads a multi-site late effects cohort study (Rad ART) and collaborate with the Childhood Cancer Survivor Study in my research on late effects.